Exchange Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Exchange Capital Management, Inc.

$581 Million
Q4 2024

A detailed history of Exchange Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 54,533 shares of BMY stock, worth $3.04 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

54,533

Previous 43,002 26.82%

Holding current value

$3.04 Million

Previous $2.23 Million 38.61%

% of portfolio

0.53%

Previous 0.38%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$51.92 - $59.94 $598,689 - $691,168	11,531 Added 26.82%	54,533 $3.08 Million
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $36,368 - $47,454	-917 Reduced 2.09%	43,002 $2.23 Million
Q2 2024 Jul 23, 2024	BUY	$40.25 - $52.99 $353,556 - $465,464	8,784 Added 25.0%	43,919 $1.82 Million
Q1 2024 Apr 18, 2024	BUY	$47.98 - $54.4 $2,399 - $2,720	50 Added 0.14%	35,135 $1.91 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $61,084 - $72,891	-1,260 Reduced 3.47%	35,085 $1.8 Million
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $80,698 - $90,233	-1,394 Reduced 3.69%	36,345 $2.11 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $32,938 - $36,572	-517 Reduced 1.35%	37,739 $2.41 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $13,864 - $15,725	211 Added 0.55%	38,256 $2.65 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $135,932 - $160,963	-1,985 Reduced 4.96%	38,045 $2.74 Million
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $3,309 - $1.96 Million	-25,461 Reduced 38.88%	40,030 $2.85 Million
Q2 2022 Jul 28, 2022	SELL	$72.62 - $79.98 $680,376 - $749,332	-9,369 Reduced 12.52%	65,491 $5.04 Million
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $5,164 - $6,192	-84 Reduced 0.11%	74,860 $5.47 Million
Q4 2021 Jan 27, 2022	BUY	$53.63 - $62.52 $8,205 - $9,565	153 Added 0.2%	74,944 $4.67 Million
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $133,724 - $156,640	-2,260 Reduced 2.93%	74,791 $4.43 Million
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $6,314 - $6,876	102 Added 0.13%	77,051 $5.15 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $334,499 - $376,213	5,637 Added 7.9%	76,949 $4.86 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $718,516 - $814,210	12,444 Added 21.14%	71,312 $4.42 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $125,484 - $139,053	2,185 Added 3.85%	58,868 $3.55 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $46,487 - $54,348	-848 Reduced 1.47%	56,683 $3.33 Million
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $47,560 - $69,115	-1,025 Reduced 1.75%	57,531 $3.21 Million
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $65,990 - $86,078	1,341 Added 2.34%	58,556 $3.76 Million
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $2.45 Million - $2.9 Million	57,215 New	57,215 $2.9 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $17,163 - $22,256	-352 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $19,426 - $21,912	352 New	352 $22,000

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.

Account

Exchange Capital Management, Inc. Bristol Myers Squibb CO Transaction History